Pharmacologic evaluation of a new series of cholinergic antagonists containing an agonist moiety.
D000109:Acetylcholine / Q000037:antagonists & inhibitors*; D000818:Animals; D001011:Aorta / Q000187:drug effects; D001285:Atropine / Q000494:pharmacology; D001561:Benzilates / Q000494:pharmacology*; D002217:Carbachol / Q000037:antagonists & inhibitors; D055598:Chemical Phenomena; D002621:Chemistry; D002712:Chlorides / Q000494:pharmacology*; D004155:Diphenhydramine / Q000494:pharmacology; D005260:Female; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D007583:Jejunum / Q000187:drug effects; D009119:Muscle Contraction / Q000187:drug effects*; D010656:Phenylephrine / Q000037:antagonists & inhibitors; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology*; D011817:Rabbits; D011955:Receptors, Drug
D001561:Benzilates; D002712:Chlorides; D006634:Histamine H1 Antagonists; D000644:Quaternary Ammonium Compounds; D011955:Receptors, Drug; D010656:Phenylephrine; D001285:Atropine; D004155:Diphenhydramine; D002217:Carbachol; D000109:Acetylcholine